184 related articles for article (PubMed ID: 18005148)
1. Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group.
Nicholson A; Berger K; Bohn R; Carcao M; Fischer K; Gringeri A; Hoots K; Mantovani L; Schramm W; van Hout BA; Willan AR; Feldman BM
Haemophilia; 2008 Jan; 14(1):127-32. PubMed ID: 18005148
[TBL] [Abstract][Full Text] [Related]
2. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
[TBL] [Abstract][Full Text] [Related]
3. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
4. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.
Evers S; Goossens M; de Vet H; van Tulder M; Ament A
Int J Technol Assess Health Care; 2005; 21(2):240-5. PubMed ID: 15921065
[TBL] [Abstract][Full Text] [Related]
5. Costing and perspective in published cost-effectiveness analysis.
Neumann PJ
Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic use of factor VIII: an economic evaluation.
Bohn RL; Avorn J; Glynn RJ; Choodnovskiy I; Haschemeyer R; Aledort LM
Thromb Haemost; 1998 May; 79(5):932-7. PubMed ID: 9609224
[TBL] [Abstract][Full Text] [Related]
7. Towards a European consensus on conducting and reporting health economic evaluations--a report from the ISPOR Inaugural European Conference.
Goetghebeur MM; Rindress D
Value Health; 1999; 2(4):281-7. PubMed ID: 16674318
[TBL] [Abstract][Full Text] [Related]
8. Costing methodology in laparoscopic surgery.
Kesteloot K; Demoulin L; Penninckx F
Acta Chir Belg; 1996; 96(6):252-60. PubMed ID: 9008765
[TBL] [Abstract][Full Text] [Related]
9. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
BMJ; 2013 Mar; 346():f1049. PubMed ID: 23529982
[TBL] [Abstract][Full Text] [Related]
10. Assessment of transparency of cost estimates in economic evaluations of patient safety programmes.
Fukuda H; Imanaka Y
J Eval Clin Pract; 2009 Jun; 15(3):451-9. PubMed ID: 19366392
[TBL] [Abstract][Full Text] [Related]
11. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
Giraldes Mdo R
Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
[TBL] [Abstract][Full Text] [Related]
12. Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis.
Bansback N; Maetzel A; Drummond M; Anis A; Marra C; Conway P; Boers M; Tugwell P; Boonen A
J Rheumatol; 2007 May; 34(5):1178-83. PubMed ID: 17477483
[TBL] [Abstract][Full Text] [Related]
13. Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions.
Manco-Johnson MJ; Pettersson H; Petrini P; Babyn PS; Bergstrom BM; Bradley CS; Doria AS; Feldman BM; Funk S; Hilliard P; Kilcoyne R; Lundin B; Nuss R; Rivard G; Schoenmakers MA; Van den Berg M; Wiedel J; Zourikian N; Blanchette VS
Haemophilia; 2004 Oct; 10 Suppl 4():88-93. PubMed ID: 15479378
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis in adults with haemophilia.
Hay CR
Haemophilia; 2007 Sep; 13 Suppl 2():10-5. PubMed ID: 17685918
[TBL] [Abstract][Full Text] [Related]
15. Issues of consensus and debate for economic evaluation in rheumatology.
Coyle D; Welch V; Shea B; Gabriel S; Drummond M; Tugwell P
J Rheumatol; 2001 Mar; 28(3):642-7. PubMed ID: 11296975
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
17. Presentation of economic evaluation results.
Chaikledkaew U; Teerawattananon Y
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S66-73. PubMed ID: 19253489
[TBL] [Abstract][Full Text] [Related]
18. How do we evaluate the economics of health care?
Kumar S; Williams AC; Sandy JR
Eur J Orthod; 2006 Dec; 28(6):513-9. PubMed ID: 17035484
[TBL] [Abstract][Full Text] [Related]
19. In search of the evidentiary foundation of published Canadian economic evaluations (2001-06).
Tarride JE; Lim ME; Bowen JM; McCarron CE; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
Int J Technol Assess Health Care; 2009 Apr; 25(2):214-21. PubMed ID: 19331712
[TBL] [Abstract][Full Text] [Related]
20. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
